Insider Trading & Ownership - Morosini Deborah

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Morosini Deborah
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-12-15
Sale
2021-12-17
5:20 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
28,751$13$373,763271,489
(Direct)
View
2021-11-16
Sale
2021-11-18
6:42 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
28,751$15.88$456,532196,489
(Direct)
View
2021-04-29
Sale
2021-04-30
6:22 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
3,223$40.29$129,8534,767
(Direct)
View
2021-04-08
Sale
2021-04-15
7:11 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
100$40$4,0007,990
(Direct)
View
2021-04-07
Sale
2021-04-09
5:52 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
1,000$40.04$40,0438,090
(Direct)
View
2020-09-29
Purchase
2020-09-29
8:08 pm
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
444$19$8,436444
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-02-15
Option Award
2022-02-17
7:08 pm
N/A
2032-02-14
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
90,000$090,000
(Direct)
View
2021-12-15
Exercise
2021-12-17
5:20 pm
N/A
2030-03-26
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
28,751$0271,489
(Direct)
View
2021-12-15
Exercise
2021-12-17
5:20 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
3,016$1.89271,489
(Direct)
View
2021-12-15
Exercise
2021-12-17
5:20 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
25,735$12.85271,489
(Direct)
View
2021-11-16
Exercise
2021-11-18
6:42 pm
N/A
2030-09-01
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
28,751$0196,489
(Direct)
View
2021-11-16
Exercise
2021-11-18
6:42 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
28,751$12.85196,489
(Direct)
View
2021-07-20
Option Award
2021-07-22
6:14 pm
N/A
2031-07-19
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
85,000$085,000
(Direct)
View
2021-04-29
Exercise
2021-04-30
6:22 pm
N/A
2030-03-26
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
3,223$04,767
(Direct)
View
2021-04-29
Exercise
2021-04-30
6:22 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
3,223$1.894,767
(Direct)
View
2021-04-08
Exercise
2021-04-15
7:11 pm
N/A
2030-03-26
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
100$07,990
(Direct)
View
2021-04-08
Exercise
2021-04-15
7:11 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
100$1.897,990
(Direct)
View
2021-04-07
Exercise
2021-04-09
5:52 pm
N/A
2030-03-26
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
1,000$08,090
(Direct)
View
2021-04-07
Exercise
2021-04-09
5:52 pm
N/A
N/A
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
1,000$1.898,090
(Direct)
View

Ownership
2020-09-24
7:23 pm
N/A
2030-03-26
Prelude Therapeutics IncPRLDMorosini Deborah
EVP, Chief of Clinical Affairs
0$0332,870
(Direct)
View